95 related articles for article (PubMed ID: 6247259)
1. Usefulness of orally active angiotensin I converting enzyme inhibitor (SQ 14,225) in the treatment of malignant hypertension.
Abe I; Kawasaki T; Ueno M; Kawano Y; Uezono K; Ogata M; Kawazoe N; Omae T; Fukiyama K
Fukuoka Igaku Zasshi; 1980 Mar; 71(3):157-66. PubMed ID: 6247259
[No Abstract] [Full Text] [Related]
2. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
[No Abstract] [Full Text] [Related]
3. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
Guerrera G; Melina D
Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
[No Abstract] [Full Text] [Related]
4. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
[No Abstract] [Full Text] [Related]
5. [Antihypertensive effect of an oral angiotensin I-converting enzyme inhibitor in two cases with malignant hypertension (author's transl)].
Mizuno K; Gotho M; Tsutsui K; Yamazaki M; Shigetomi S; Kudo S; Matsui J; Haruyama K; Nakamura I; Toki T; Nagasawa S; Fukuchi S
Nihon Jinzo Gakkai Shi; 1981 Jan; 23(1):1-12. PubMed ID: 7026848
[No Abstract] [Full Text] [Related]
6. Response of malignant hypertension with refractory cardiac failure to captopril: A case report.
Levin L; Logan K
S Afr Med J; 1980 Aug; 58(5):217-8. PubMed ID: 6996155
[TBL] [Abstract][Full Text] [Related]
7. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
Guerrera G; Melina D
Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
[No Abstract] [Full Text] [Related]
9. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
Santucci A; Aguglia F; Ficara C
Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
[No Abstract] [Full Text] [Related]
10. [Angiotensin converting enzyme--captopril].
Kaneko Y; Shionoiri H; Uneda S; Fujishima S
Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
[No Abstract] [Full Text] [Related]
11. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
[TBL] [Abstract][Full Text] [Related]
12. [Use of SQ 14225 in the treatment of essential arterial hypertension].
Degli Esposti E; Chiarini C; Fusaroli M; Masi A; Santoro A; Sturani A; Zuccalà A; Zucchelli P
Clin Ter; 1981 Apr; 97(2):153-63. PubMed ID: 6263540
[No Abstract] [Full Text] [Related]
13. [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme].
Waeber B; Gavras H; Brunner HR; Chappuis P; Turini GA
Schweiz Med Wochenschr; 1978 Dec; 108(49):1981-3. PubMed ID: 219469
[TBL] [Abstract][Full Text] [Related]
14. Oral converting enzyme inhibitor in malignant hypertension.
Griswold W; McNeal R; O'Connor D; Reznik V; Mendoza S
Arch Dis Child; 1982 Mar; 57(3):235-7. PubMed ID: 6280623
[TBL] [Abstract][Full Text] [Related]
15. Effective use of captopril (angiotensin I-converting enzyme inhibitor) in severe childhood hypertension.
Friedman A; Chesney RW; Ball D; Goodfriend T
J Pediatr; 1980 Oct; 97(4):664-7. PubMed ID: 6999143
[No Abstract] [Full Text] [Related]
16. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
[TBL] [Abstract][Full Text] [Related]
17. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
Stanek B; Templ H; Pohanka E; Silberbauer K
Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
[No Abstract] [Full Text] [Related]
18. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
19. [Long term treatment of resistant hypertension with captopril (author's transl)].
Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
[TBL] [Abstract][Full Text] [Related]
20. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
Aberg H; Frithz G; Mörlin C
Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
